Pharvaris NV (PHVS)
22.68
+0.08
(+0.35%)
USD |
NASDAQ |
May 06, 16:00
22.59
-0.09
(-0.40%)
After-Hours: 20:00
Pharvaris Cash from Investing (TTM): -0.0974M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0974M |
| September 30, 2023 | -0.0968M |
| June 30, 2023 | -0.1371M |
| March 31, 2023 | -0.1219M |
| December 31, 2022 | -0.1311M |
| September 30, 2022 | -0.1827M |
| June 30, 2022 | -0.1664M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.1713M |
| December 31, 2021 | -0.1539M |
| September 30, 2021 | -0.0799M |
| June 30, 2021 | -0.0692M |
| March 31, 2021 | -0.0454M |
| December 31, 2020 | -0.0491M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.1827M
Minimum
Sep 2022
-0.0454M
Maximum
Mar 2021
-0.1156M
Average
-0.1219M
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
| uniQure NV | -205.69M |
| ProQR Therapeutics NV | 4.631M |
| Merus NV | -27.02M |
| argenx SE | -- |
| Pharming Group | -129.39M |